Palak Trivedi Selected Research

Sclerosing Cholangitis

3/2023	PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis.
1/2023	CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.
1/2022	Emerging drugs for the treatment of primary sclerosing cholangitis.
1/2020	Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
1/2017	norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Palak Trivedi Research Topics

Disease

5	Cholestasis 10/2023 - 01/2017
5	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2023 - 01/2019
5	Fibrosis (Cirrhosis) 10/2023 - 01/2020
5	Sclerosing Cholangitis 03/2023 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 03/2023 - 01/2022
2	Pruritus (Itching) 01/2024 - 01/2021
2	Autoimmune Hepatitis 10/2023 - 10/2019
1	progressive familial intrahepatic 1 Cholestasis 01/2024
1	Alcoholic Fatty Liver 10/2023
1	COVID-19 10/2023
1	Breakthrough Infections 10/2023
1	Liver Diseases (Liver Disease) 10/2023
1	Virus Diseases (Viral Diseases) 10/2023
1	Inflammation (Inflammations) 01/2023
1	Rare Diseases (Rare Disease) 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Disease Progression 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Cholangitis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Bile Duct Diseases (Bile Duct Disease) 01/2017

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
3	Alkaline PhosphataseIBA 07/2023 - 01/2019
2	Bile Acids and Salts (Bile Acids)IBA 01/2024 - 03/2023
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 07/2023 - 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 10/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2023
1	seladelparIBA 10/2023
1	COVID-19 VaccinesIBA 10/2023
1	Peptides (Polypeptides)IBA 10/2023
1	Messenger RNA (mRNA)IBA 10/2023
1	VaccinesIBA 10/2023
1	cilofexorIBA 03/2023
1	streptococcal polysaccharide type III group BIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Sirtuin 1IBA 01/2022
1	obeticholic acidIBA 01/2021
1	Fibric Acids (Fibrates)IBA 01/2021
1	vedolizumabIBA 01/2020
1	IntegrinsIBA 01/2020
1	SteroidsIBA 10/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	BilirubinIBA 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019
1	AcidsIBA 01/2017

Therapy/Procedure

5	Liver Transplantation 10/2023 - 01/2019
4	Therapeutics 01/2022 - 01/2017
3	Transplantation 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2024